Dizlin Competitors and Similar CompaniesClear all
Dizlin's competitors and similar companies include AFFiRiS, Addex Therapeutics, IRLAB Therapeutics and AlzeCure Pharma.
 Dizlin Dizlin Pharmaceuticals is a pharmaceutical research company developing treatments for Parkinson's disease. |  Addex Therapeutics Addex Therapeutics, a development-stage biopharmaceutical company, discovers small-molecule pharmaceutical products. |  IRLAB Therapeutics IRLAB Therapeutics is a biotechnology company focused on Parkinson's disease (PD). |  AlzeCure Pharma AlzeCure Pharma is a company developing diagnostics and therapeutics for Parkinson’s, Alzheimer’s diseases, and related neurodegenerative disorders. | ||
Founding Date | Founding Date 2003 | Founding Date 2003 | Founding Date 2002 | Founding Date 2013 | Founding Date 2012 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Göteborg, SE HQ | Locations Wien, AT HQ | Locations Plan-les-Ouates, CH HQ San Francisco, US | Locations Göteborg, SE HQ | Locations Huddinge, SE HQ |
Employees | Employees 6 | Employees 3 | Employees 23 | Employees 30 | Employees 11 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 63.7 m | Valuation ($) 14.9 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) CHF404k (FY, 2024) | Revenue (est.) kr57.5m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit CHF449k (FY, 2024) | Gross profit kr62.8m (FY, 2025) | Gross profit kr1.6m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income (CHF6.9m) (FY, 2024) | Net income (kr110m) (FY, 2025) | Net income (kr47.7m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 34.1m | Total funding raised $ 94.7m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
AFFiRiS
HQ
Wien, AT
Employees
3
AFFiRiS is a company that delivers therapies to patients with neurodegenerative diseases.
View companyAddex Therapeutics
HQ
Plan-les-Ouates, CH
Employees
23
Addex Therapeutics, a development-stage biopharmaceutical company, discovers small-molecule pharmaceutical products.
View companyIRLAB Therapeutics
HQ
Göteborg, SE
Employees
30
IRLAB Therapeutics is a biotechnology company focused on Parkinson's disease (PD).
View companyAlzeCure Pharma
HQ
Huddinge, SE
Employees
11
AlzeCure Pharma is a company developing diagnostics and therapeutics for Parkinson’s, Alzheimer’s diseases, and related neurodegenerative disorders.
View company